OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice
Haruko Nakamura, Aoi Takahashi-Jitsuki, Hiroko Makihara, et al.
Neurochemistry International (2018) Vol. 119, pp. 207-217
Closed Access | Times Cited: 19

Showing 19 citing articles:

Endothelial cell‐derived extracellular vesicles alter vascular smooth muscle cell phenotype through high‐mobility group box proteins
Michael Boyer, Yayoi Kimura, Tomoko Akiyama, et al.
Journal of Extracellular Vesicles (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 64

CDK5: A Unique CDK and Its Multiple Roles in the Nervous System
Nicole Cortés, Leonardo Guzmán‐Martínez, Víctor Andrade, et al.
Journal of Alzheimer s Disease (2019) Vol. 68, Iss. 3, pp. 843-855
Closed Access | Times Cited: 57

Contribution of the dihydropyrimidinase-like proteins family in synaptic physiology and in neurodevelopmental disorders
Florence Desprez, Dévina C. Ung, Patrick Vourc’h, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 21

Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer’s Disease
Lei Zhang, Zhipeng Qi, Jiashuo Li, et al.
Molecular Neurobiology (2021)
Closed Access | Times Cited: 36

Semaphorin 3s signaling in the central nervous system: Mechanisms and therapeutic implication for brain diseases
Ya-Ping Lu, Yiling Luo, Zhouyue Wu, et al.
Pharmacology & Therapeutics (2025), pp. 108800-108800
Closed Access

Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder
Rut Mazón-Cabrera, Patrick Vandormael, Veerle Somers
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 26

Semaphorin 3A influences neuronal processes that are altered in patients with autism spectrum disorder: Potential diagnostic and therapeutic implications
Carmela Matrone, Gabriella Ferretti
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105338-105338
Closed Access | Times Cited: 8

Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice
Villő Muha, Ritchie Williamson, Rachel Hills, et al.
Open Biology (2019) Vol. 9, Iss. 11, pp. 190192-190192
Open Access | Times Cited: 21

Role of Semaphorins in Ischemic Stroke
Huaping Du, Yuan Xu, Li Zhu
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 12

Lacosamide intake during pregnancy increases the incidence of foetal malformations and symptoms associated with schizophrenia in the offspring of mice
Beatriz López‐Escobar, Rut Fernández‐Torres, Viviana Vargas-López, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 12

Cortical transcriptome analysis after spinal cord injury reveals the regenerative mechanism of central nervous system in CRMP2 knock-in mice
Toshio Ohshima, Ayaka Sugeno, Wenhui Piao, et al.
Neural Regeneration Research (2020) Vol. 16, Iss. 7, pp. 1258-1258
Open Access | Times Cited: 11

Inhibition of Crmp1 Phosphorylation at Ser522 Ameliorates Motor Function and Neuronal Pathology in Amyotrophic Lateral Sclerosis Model Mice
Tetsuya Asano, Haruko Nakamura, Yuko Kawamoto, et al.
eNeuro (2022) Vol. 9, Iss. 3, pp. ENEURO.0133-22.2022
Open Access | Times Cited: 7

Crmp4-KO Mice as an Animal Model for Investigating Certain Phenotypes of Autism Spectrum Disorders
Ritsuko Ohtani‐Kaneko
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2485-2485
Open Access | Times Cited: 10

Effects of the CRMP2 activator lanthionine ketimine ethyl ester on oligodendrocyte progenitor cells
Valentyna Savchenko, Sergey Kalinin, Anne I. Boullerne, et al.
Journal of Neuroimmunology (2019) Vol. 334, pp. 576977-576977
Closed Access | Times Cited: 7

Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis
Aubin Moutal, Sergey Kalinin, Kathy Kowal, et al.
ASN NEURO (2019) Vol. 11, pp. 175909141989209-175909141989209
Open Access | Times Cited: 7

Transduction Efficiency of Adenovirus Vectors in Endothelial Cells and Vascular Smooth Muscle Cells
Nikita Mokhashi, Robert Y. Choi, Stephanie Cicalese, et al.
Journal of Cardiovascular Pharmacology (2020) Vol. 75, Iss. 6, pp. 603-607
Closed Access | Times Cited: 6

Regulation of Dihydropyrimidinase-like 3 Gene Expression by MicroRNAs in PC12 Cells with Induced Ischaemia and Hypothermia
Kisang Kwon, Ji-Hye Song, Hyewon Park, et al.
Folia Biologica (2023) Vol. 69, Iss. 2, pp. 69-73
Open Access | Times Cited: 1

Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
Jeffrey L. Dupree, Pablo M. Paez, Seema K. Tiwari‐Woodruff, et al.
ASN NEURO (2022) Vol. 14, pp. 175909142211123-175909142211123
Open Access | Times Cited: 2

Page 1

Scroll to top